Cargando…

Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature

Waldenström macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL) is often differentiated from myeloma based on the presence of lytic bone lesions (LBL). However, WM/LPL can present with LBL, and management is poorly understood. We describe a case of an 81‐year‐old woman with LPL who presented wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baksh, Mizba, Jiang, Liuyan, Bhatia, Unnati, Alegria, Victoria, Sher, Taimur, Roy, Vivek, Chanan‐Khan, Asher, Ailawadhi, Sikander, Parrondo, Ricardo D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650751/ https://www.ncbi.nlm.nih.gov/pubmed/34934497 http://dx.doi.org/10.1002/ccr3.5181

Ejemplares similares

Myelomatous ascites and pleural effusion in relapsed multiple myeloma
por: Baksh, Mizba, et al.
Publicado: (2022)

Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review
por: Parrondo, Ricardo D., et al.
Publicado: (2020)

Landmark Cancer Clinical Trials and Real-World Patient Populations: Examining Race and Age Reporting
por: Jayakrishnan, Thejus, et al.
Publicado: (2021)

RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis
por: Parrondo, Ricardo D., et al.
Publicado: (2022)

The digital divide: Racial disparities in adoption and utilization of health information technology among patients with lymphoid cancers
por: Ailawadhi, Sikander, et al.
Publicado: (2023)

Anti-B Cell Maturation Antigen Chimeric Antigen Receptor T Cell Therapy for the Treatment of AL Amyloidosis and Concurrent Relapsed/Refractory Multiple Myeloma: Preliminary Efficacy and Safety
por: Das, Saurav, et al.
Publicado: (2023)

A Panel Evaluation of the Changes in the General Public’s Social-Media-Following of United States’ Public Health Departments during COVID-19 Pandemic
por: Khokhar, Areej, et al.
Publicado: (2021)

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia
por: Kumar, Vivek, et al.
Publicado: (2019)

Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia
por: Khurana, Sharad, et al.
Publicado: (2019)

AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma
por: Ailawadhi, Sikander, et al.
Publicado: (2023)

Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience
por: Yassine, Farah, et al.
Publicado: (2023)

Iopofosine I-131 treatment in late-line patients with relapsed/refractory multiple myeloma post anti-BCMA immunotherapy
por: Longcor, Jarrod, et al.
Publicado: (2022)

Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma
por: Parrondo, Ricardo D., et al.
Publicado: (2022)

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes
por: Swaika, Abhisek, et al.
Publicado: (2017)

Prevention Of Skeletal Related Events In Multiple Myeloma: Focus On The RANK-L Pathway In The Treatment Of Multiple Myeloma
por: Parrondo, Ricardo D, et al.
Publicado: (2019)

Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
por: Parrondo, Ricardo D., et al.
Publicado: (2022)

Amyloid myopathy as the presenting feature of lymphoplasmacytic lymphoma
por: Guduru, Zain, et al.
Publicado: (2017)

Ibrutinib response in cutaneous transformed lymphoplasmacytic lymphoma
por: Lindholm, Kaleigh E., et al.
Publicado: (2021)

Targeted treatment for chronic lymphocytic leukemia
por: Masood, Aisha, et al.
Publicado: (2011)

Ureteral amyloidosis in the context of lymphoplasmacytic lymphoma and systemic amyloidosis
por: Riaza Montes, María, et al.
Publicado: (2021)

Bilateral auricular lymphoplasmacytic lymphoma: barely mere coincidence.()()
por: Yavorkovsky, Leonid L, et al.
Publicado: (2021)

Disseminated pulmonary AL amyloidosis associated with lymphoplasmacytic lymphoma
por: Janjetovic, Snjezana, et al.
Publicado: (2021)

Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib
por: Hampel, Paul J., et al.
Publicado: (2022)

Immunophenotyping of Waldenströms Macroglobulinemia Cell Lines Reveals Distinct Patterns of Surface Antigen Expression: Potential Biological and Therapeutic Implications
por: Paulus, Aneel, et al.
Publicado: (2015)

How to diagnose lymphoplasmacytic lymphoma without infiltration of plasmacytoid lymphocytes?
por: Kassir, Ali El, et al.
Publicado: (2021)

Cytogenetic aberrations of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia in Chinese patients
por: Xiong, Wenjie, et al.
Publicado: (2023)

Primary Bone Lymphoplasmacytic Lymphoma Presenting with Spinal Cord Compression: A Case Report
por: Lei, Yang, et al.
Publicado: (2013)

Lymphoplasmacytic Plaque in Children
por: Seo, Jimyung, et al.
Publicado: (2016)

Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?
por: Boiza-Sánchez, Macarena, et al.
Publicado: (2020)

Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma
por: Bansal, Radhika, et al.
Publicado: (2023)

Transformed lymphoplasmacytic lymphoma involving the main carina: A case report
por: NAKAO, MAKOTO, et al.
Publicado: (2013)

Pseudo liposarcomatous plasma cells in a patient with liposarcoma and lymphoplasmacytic lymphoma
por: Schmidt, Adrian, et al.
Publicado: (2018)

Rituximab use for lymphoplasmacytic lymphoma during continuous renal replacement therapy
por: Simões, Marco, et al.
Publicado: (2019)

Primary Isolated Lymphoplasmacytic Lymphoma (LPL) of the Stomach: A Case Report
por: Attallah, Hany S., et al.
Publicado: (2020)

A Unique Case of Renal Infiltration by Lymphoplasmacytic Lymphoma with Cast Nephropathy
por: Malhotra, Kiran P., et al.
Publicado: (2020)

Lymphoplasmacytic Lymphoma with Only Lambda Light Chain Monoclonal Paraprotein Expression
por: Cautha, Sandhya, et al.
Publicado: (2022)

A Rare Case of Laryngeal Non-IgM Lymphoplasmacytic Lymphoma
por: Hong, Michelle K, et al.
Publicado: (2022)

Lung consolidation as a rare presentation of lymphoplasmacytic lymphoma with extramedullary Waldenström’s macroglobulinemia
por: Abdulfattah, Omar, et al.
Publicado: (2018)

Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment
por: Schlevogt, Bernhard, et al.
Publicado: (2019)

Lymphoplasmacytic lymphoma infiltrating both lacrimal glands in a patient with Waldenström's macroglobulinemia
por: Vangsted, Andreas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ojt89s6vb6sdm47ublo0j1j03i